Amantadine Hydrochloride/Chlorphenamine Maleate/Aminophenazone

盐酸金刚烷胺/马来酸氯苯那敏/氨基比林

Report date: 2023/08/09 18:30:34

Base Information

Drug NameAmantadine Hydrochloride/Chlorphenamine Maleate/Aminophenazone
Drug Alias Name复方金刚烷胺氨基比林
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsHistamine H1 receptor antagonists
TargetsGlutamate [NMDA] receptorHistamine H1 receptor
Therapy Area/IndicationsCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Amantadine HydrochlorideChlorphenamine MaleateAminophenazone
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A